Industry

Pulmonary Function Testing Systems Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Cart-Based PFT Systems and Stationary PFT Systems), Test Type (Spirometry, Lung Volume, Gas Exchange Testing, Maximum Voluntary Ventilation, Oxygen Titration Test, and Others), Component (Hardware, Software, and Services), Application (Chronic Obstructive Pulmonary Disorder, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease, and Others), and End User (Hospitals, Specialty Clinics, and Diagnostic Laboratories)

Report Code : 

TIPRE00017822

No. of Pages : 220
Published Month : Jan 2023
Category : Life Sciences

The pulmonary function testing systems market size is expected to reach US$ 401.83 million by 2028 from US$ 274.10 million in 2022. The pulmonary function testing systems market is estimated to record a CAGR of 6.6% from 2022 to 2028.

Pulmonary functioning testing (PFT) is a set of noninvasive tests used to measure how well a patient’s lungs are working. These tests are important in diagnosing and treating those with respiratory diseases. In order to perform the tests and obtain accurate results, it is important to use the right types of PFT equipment and machines. The pulmonary functioning testing system is made up of several devices that are used to measure different aspects of lung function. This can include how well the lungs take in and expel air, how efficiently they transfer oxygen to the blood, and how much air they can hold. PFTs measure lung volumes, capacities, and the amount of gas exchange. The rising incidence of lung-related disorders and occupational lung diseases is contributing to the growing pulmonary function testing systems market size. However, the risk of cross-contamination and the lack of skilled professionals are hampering the market growth.

The pulmonary function testing systems market has been segmented based on type, test type, component, application, end user, and geography. In terms of geography, the market is primarily segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing parameters such as pulmonary function testing systems market trends, technological advancements, market dynamics, and the competitive landscape analysis of leading market players.

Market Insights

Rising Incidence of Lung-Related Disorders

According to the British Lung Foundation 2023 report, ~10,000 people in the UK are newly diagnosed with lung disease every week. Additionally, lung diseases account for more than 70,00,000 hospital admissions, with 6 million inpatient bed-days in the UK annually. Therefore, pulmonary function testing (PFT) systems prove useful in diagnosing and monitoring. The PFT systems provide accurate results, particularly lung volume, capacity, rates of flow, and gas exchange. Additionally, PFT systems utilization assists in assessing treatment for asthma, emphysema, and other chronic lung problems. Through the assessment of lung volumes, capacities, rates of flow, and gas exchange, PFTs can provide information that can be evaluated by physicians to help diagnose certain lung disorders effectively and decide the right treatment for patients. Further, PFTs are noninvasive procedures and are usually recommended by physicians for patients with no hospital stay. Commercial pulmonary function testing systems available in the market include spirometry. Spirometry testing is useful for determining if the patient is suffering from lung disease, type of lung disease, progression of the lung disease, and impairment of lung disease. Spirometry measures airflow and can evaluate a broad range of lung diseases among patients. Thus, the rising incidence of lung-related disorders is fueling the use of pulmonary function testing systems.

Type-Based Insights

Based on type, the pulmonary function testing systems market is segmented into cart-based PFT systems and stationary PFT systems. The cart-based segment held a larger share of the market in 2022. Moreover, the cart-based segment is anticipated to register a higher CAGR in the market during the forecast period.

Test Type-Based Insights

In terms of test type, the pulmonary function testing systems market has been segmented into spirometry, lung volume, gas exchange testing, maximal voluntary ventilation, oxygen titration tests, and others. The spirometry segment held the largest share of the market in 2022. Moreover, the lung volume segment is anticipated to register the highest CAGR in the market during the forecast period.

Component-Based Insights

Based on component, the pulmonary function testing systems market has been segmented into hardware, software, and services. The hardware segment held the largest share of the market in 2022. The software segment is anticipated to register the highest CAGR in the market during the forecast period.

Application-Based Insights

Based on application, the pulmonary function testing systems market has been segmented into chronic obstructive pulmonary disease (COPD), asthma, chronic shortness of breath, restrictive lungs diseases, and others. The chronic obstructive pulmonary disease (COPD) segment held the largest share of the market in 2022. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period.

End User-Based Insights

Based on end user, the pulmonary function testing systems market has been segmented into hospitals, specialty clinics, and diagnostic centers. The hospitals segment held the largest share of the market in 2022. The specialty clinics segment is anticipated to register the highest CAGR in the market during the forecast period.

COVID-19 is a respiratory system infection that may rapidly cause pneumonia-like symptoms and chest infections. This may result in lowering the health conditions of the patient. The ventilators help manage the gas exchange of the patients. Due to the COVID-19 outbreak, there was a very high demand for pulmonary function testing systems. American Lung Association and Centers for Disease Control and Prevention recommended that patients with mild symptoms of COVID-19 carry out pulmonary function testing to check the lung capacity of the patient. Pulmonary function testing is an ideal tool for assessing the physiological impact of a virus that largely attacks the cardiopulmonary system. The technology measuring airflow, lung volumes, and the ability for oxygen and carbon dioxide to transfer between the alveoli and the bloodstream are well established, and facilities to perform these tests are found around the US.

Companies in the pulmonary function testing systems market commonly adopt product launches and expansion strategies to expand their footprint across the world and meet the growing demand. Their focus on product innovation allows them to cater to changing customer demands and maintain their brand name across the globe.

  • In June 2022, ndd Medical Technologies (ndd) updated the entire EasyOne product range, including the EasyOne Air, Easy on-PC, EasyOne Pro, and EasyOne Pro LAB, to be compliant with the ATS/ERS Standardization of Spirometry 2019.
  • In April 2021, Vyaire Medical announced the European launch of ArtiQ.PFT, an automated tool driven by artificial intelligence that instantly interprets pulmonary function tests (PFTs). ArtiQ.PFT is the first cloud-based PFT solution that leverages artificial intelligence.

In terms of geography, the global pulmonary function testing systems market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Pulmonary Function Testing Systems Market Regional Insights

The regional trends and factors influencing the Pulmonary Function Testing Systems Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Pulmonary Function Testing Systems Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

  • Get the Regional Specific Data for Pulmonary Function Testing Systems Market

Pulmonary Function Testing Systems Market Report Scope

Report Attribute Details
Market size in 2022 US$ 274.10 Million
Market Size by 2028 US$ 401.83 Million
Global CAGR (2022 - 2028) 6.6%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Type
  • Cart-Based PFT Systems and Stationary PFT Systems
By Test Type
  • Spirometry
  • Lung Volume
  • Gas Exchange Testing
  • Maximum Voluntary Ventilation
  • Oxygen Titration Test
By Component
  • Hardware
  • Software
  • Services
By Application
  • Chronic Obstructive Pulmonary Disorder
  • Asthma
  • Chronic Shortness of Breath
  • Restrictive Lung Disease
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • SCHILLER
  • COSMED srl
  • MGC Diagnostics Corporation
  • Ganshoran Medizin Electronic
  • ndd Medical Technologies
  • Morgan Scientific Inc.
  • Pulm One Advanced Medical Devices Ltd
  • CHEST M.I., Inc
  • Vyaire Medical, Inc.

  • Pulmonary Function Testing Systems Market Players Density: Understanding Its Impact on Business Dynamics

    The Pulmonary Function Testing Systems Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Pulmonary Function Testing Systems Market are:

    1. SCHILLER
    2. COSMED srl
    3. MGC Diagnostics Corporation
    4. Ganshoran Medizin Electronic
    5. ndd Medical Technologies

    Disclaimer: The companies listed above are not ranked in any particular order.



    • Get the Pulmonary Function Testing Systems Market top key players overview

    Company Profiles

    • COSMED Srl
    • MGC Diagnostics Corp
    • Morgan Scientific Inc
    • Minato Medical Science Co Ltd
    • Schiller AG
    • Chest MI Inc
    • Vyaire Medical Inc
    • ndd Medical Technologies Inc
    • PulmOne Advanced Medical Devices Ltd
    • KoKo PFT Ltd

    The List of Companies - Pulmonary Function Testing Systems Market

    1. SCHILLER
    2. COSMED srl
    3. MGC Diagnostics Corporation
    4. Ganshoran Medizin Electronic
    5. ndd Medical Technologies
    6. Morgan Scientific Inc.
    7. Pulm One Advanced Medical Devices Ltd
    8. CHEST M.I., Inc
    9. Vyaire Medical, Inc.
    10. Koko LLC
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the pulmonary function testing systems market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global pulmonary function testing systems market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global sports medicine devices market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
    Download Sample

    Frequently Asked Questions

    Who are the key players in the pulmonary function testing systems market?

    COSMED Srl, MGC Diagnostics Corp, Morgan Scientific Inc, Minato Medical Science Co Ltd, Schiller AG, Chest MI Inc, Vyaire Medical Inc, ndd Medical Technologies Inc, PulmOne Advanced Medical Devices Ltd, KoKo PFT Ltd, and among others are among the leading companies operating in the pulmonary function testing systems market.

    What is the regional market scenario of the pulmonary function testing systems market?

    Global pulmonary function testing systems market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.

    Which end user segment held the largest market share in the pulmonary function testing systems market?

    Hospitals segment dominated the global pulmonary function testing systems market and accounted for the largest market share during the forecast period of 2022-2028.

    Which application segment held the largest market share in the pulmonary function testing systems market?

    Based on the application, chronic obstructive pulmonary disorder segment took the forefront leaders in the worldwide market by accounting largest share in 2021.

    Which type segment led the pulmonary function testing systems market?

    Based on type segment, the cart-based PFT systems segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

    What are the driving factors for the pulmonary function testing systems market across the globe?

    Rising incidence of lung-related disorders and occupational lung diseases are the most significant factors responsible for the overall market growth.

    What is meant by the pulmonary function testing systems market?

    Pulmonary functioning testing (PFT) is a set of noninvasive tests that are used to measure how well a patient’s lungs are working. This is important in the diagnosis and treatment of those with respiratory diseases. In order to perform the tests and obtain accurate results, it is important to use the right types of PFT equipment and machines. There are several different devices in system. Pulmonary functioning testing system is made up of several devices that are used to measure different aspects of lung function. This can include how well the lungs take in and expel air, how efficiently they transfer oxygen to the blood, and how much air the lungs can hold. PFT’s measure lung volumes, capacities, and the amount of gas exchange.